North China Pharmaceutical Co Ltd (600812) — Free Cash Flow Generation Index
North China Pharmaceutical Co Ltd (600812) has a Free Cash Flow Generation Index of 0.15x as of September 2025. Free cash flow of CN¥25.86 Million represents 0% of operating cash flow (CN¥170.24 Million). Explore North China Pharmaceutical Co Ltd capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
North China Pharmaceutical Co Ltd Free Cash Flow Generation Index (2000–2025)
Historical FCF Generation Index trend for North China Pharmaceutical Co Ltd across 22 annual periods. For the full cash flow conversion analysis, see 600812 operating cash flow.
Annual Free Cash Flow Generation for North China Pharmaceutical Co Ltd (2000–2025)
Year-by-year Free Cash Flow Generation Index for North China Pharmaceutical Co Ltd. Check North China Pharmaceutical Co Ltd total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.54x | CN¥634.53 Million | CN¥1.18 Billion | CN¥542.01 Million | ▲ +48.9% |
| 2024 | 0.36x | CN¥445.35 Million | CN¥1.23 Billion | CN¥784.22 Million | ▼ -7.5% |
| 2023 | 0.39x | CN¥401.23 Million | CN¥1.02 Billion | CN¥623.04 Million | ▼ -13.5% |
| 2022 | 0.45x | CN¥454.81 Million | CN¥1.00 Billion | CN¥549.58 Million | ▼ -5.4% |
| 2021 | 0.48x | CN¥502.75 Million | CN¥1.05 Billion | CN¥547.50 Million | ▲ +241.4% |
| 2020 | -0.34x | CN¥-254.68 Million | CN¥752.15 Million | CN¥1.01 Billion | ▼ -385.3% |
| 2019 | 0.12x | CN¥87.00 Million | CN¥732.97 Million | CN¥645.97 Million | ▼ -65.7% |
| 2018 | 0.35x | CN¥267.69 Million | CN¥774.33 Million | CN¥506.64 Million | ▲ +188.3% |
| 2017 | -0.39x | CN¥-112.44 Million | CN¥287.25 Million | CN¥399.69 Million | ▲ +80.5% |
| 2015 | -2.00x | CN¥-245.32 Million | CN¥122.50 Million | CN¥367.81 Million | ▼ -8.1% |
| 2014 | -1.85x | CN¥-167.73 Million | CN¥90.56 Million | CN¥258.30 Million | ▲ +53.6% |
| 2011 | -3.99x | CN¥-909.21 Million | CN¥227.60 Million | CN¥1.14 Billion | ▼ -726.2% |
| 2009 | 0.64x | CN¥645.03 Million | CN¥1.01 Billion | CN¥366.10 Million | ▼ -26.9% |
| 2008 | 0.87x | CN¥947.52 Million | CN¥1.09 Billion | CN¥138.00 Million | ▲ +2.4% |
| 2007 | 0.85x | CN¥566.10 Million | CN¥664.37 Million | CN¥98.27 Million | ▼ -6.7% |
| 2006 | 0.91x | CN¥545.39 Million | CN¥597.12 Million | CN¥51.72 Million | ▲ +418.3% |
| 2005 | 0.18x | CN¥39.50 Million | CN¥224.17 Million | CN¥184.67 Million | ▲ +243.5% |
| 2004 | -0.12x | CN¥-38.11 Million | CN¥310.39 Million | CN¥348.50 Million | ▼ -151.8% |
| 2003 | 0.24x | CN¥137.54 Million | CN¥580.32 Million | CN¥442.77 Million | ▼ -65.9% |
| 2002 | 0.70x | CN¥513.82 Million | CN¥738.50 Million | CN¥224.68 Million | ▲ +45.6% |
| 2001 | 0.48x | CN¥175.49 Million | CN¥367.28 Million | CN¥191.79 Million | ▲ +77.3% |
| 2000 | 0.27x | CN¥35.97 Million | CN¥133.49 Million | CN¥97.52 Million | — |